Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...

Kiora Pharmaceuticals secures a patent for KIO-104, enhancing treatment options for ocular diseases and extending market exclusivity until 2043.

Ocular Therapeutix announced the company’s conference participation in the upcoming annual OIS Retina Innovation Summit, the American Society of Retina Specialists (ASRS), and Women in Ophthalmology ...

The completion of the full BLA submission is anticipated in early 2026 and is eligible for priority review under the program’s fast-track designation.

Sanofi's SAR446597 receives FDA fast track designation, offering a promising one-time gene therapy for geographic atrophy and reducing treatment frequency.

Advertorial: Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy? The triad of inflammation, neuropathy, and vasculopathy plays a key role ...

Researcher Adam Dubis, PhD, from John A. Moran Eye Center, is playing a role in the use of artificial intelligence (AI) in eye care. 1 Dubis co-founded German-based health tech company deepeye Medical ...

The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and the promise of gene therapy advancements.

Newsletter Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.